<table id="_RefID06324C2B1E90491FA802592A24CCC5AA" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1. Select Mean (± S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin </caption>
<col width="40%"></col>
<col width="20%"></col>
<col width="20%"></col>
<col width="20%"></col>
<tbody>
<tr>
<td align="center" stylecode="Botrule Lrule Toprule ">
<paragraph>Subject Groups: metformin dose<footnote id="_RefID7BC1B5BA1ACD458FBFBE19338D2E3EA0">All doses given fasting except the first 18 doses of the multiple dose studies;</footnote> (number of subjects)</paragraph>
</td>
<td align="center" stylecode="Botrule Lrule Toprule ">
<paragraph>Cmax<footnote id="_RefID20CAB6E0E05142B38AEECF992FC4497C">Peak plasma concentration;</footnote> (mcg/mL)</paragraph>
</td>
<td align="center" stylecode="Botrule Lrule Toprule ">
<paragraph>T<sub>max</sub>
<footnote id="_RefIDED0D4BE37D55437AACEDA7B4F39DC4D7">Time to peak plasma concentration;</footnote>(hrs)</paragraph>
</td>
<td align="center" stylecode="Botrule Toprule ">
<paragraph>Renal Clearance<br/>(mL/min)</paragraph>
</td>
</tr>
<tr>
<td colspan="4" stylecode="Botrule ">
<paragraph>Healthy, nondiabetic adults:</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>500 mg single dose (24)</paragraph>
</td>
<td align="center">
<paragraph>1.03 (± 0.33)</paragraph>
</td>
<td align="center">
<paragraph>2.75 (± 0.81)</paragraph>
</td>
<td align="center">
<paragraph>600 (± 132)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>850 mg single dose (74) <footnote id="_RefIDA49F6B6347E2484C9E22DE5C1826F917">Combined results (average means) of five studies: mean age 32 years (range 23 to 59 years).</footnote>
</paragraph>
</td>
<td align="center">
<paragraph>1.60 (± 0.38)</paragraph>
</td>
<td align="center">
<paragraph>2.64 (± 0.82)</paragraph>
</td>
<td align="center">
<paragraph>552 (± 139)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>850 mg three times daily<br/>for 19 doses <footnote id="_RefID8C69AF69CAF54214ADD71555B57C28B3">Kinetic study done following dose 19, given fasting.</footnote> (9)</paragraph>
</td>
<td align="center">
<paragraph>2.01 (± 0.42)</paragraph>
</td>
<td align="center">
<paragraph>1.79 (± 0.94)</paragraph>
</td>
<td align="center">
<paragraph>642 (± 173)</paragraph>
</td>
</tr>
<tr>
<td colspan="4" stylecode="Botrule ">
<paragraph>Adults with type 2 diabetes:</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>850 mg single dose (23)</paragraph>
</td>
<td align="center">
<paragraph>1.48 (± 0.5)</paragraph>
</td>
<td align="center">
<paragraph>3.32 (±1.08)</paragraph>
</td>
<td align="center">
<paragraph>491 (± 138)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>850 mg three times daily<br/>for 19 doses <footnoteref idref="_RefID8C69AF69CAF54214ADD71555B57C28B3"></footnoteref> (9)</paragraph>
</td>
<td align="center">
<paragraph>1.90 (±0.62)</paragraph>
</td>
<td align="center">
<paragraph>2.01 (± 1.22)</paragraph>
</td>
<td align="center">
<paragraph>550 (± 160)</paragraph>
</td>
</tr>
<tr>
<td colspan="4" stylecode="Botrule ">
<paragraph>Elderly<footnote id="_RefIDB318E656FDB04868A0DA3EFD9F044A3D">Elderly subjects, mean age 71 years (range 65 to 81 years).</footnote>, healthy nondiabetic adults:</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>850 mg single dose (12)</paragraph>
</td>
<td align="center">
<paragraph>2.45 (± 0.70)</paragraph>
</td>
<td align="center">
<paragraph>2.71 (± 1.05)</paragraph>
</td>
<td align="center">
<paragraph>412 (± 98)</paragraph>
</td>
</tr>
<tr>
<td colspan="4" stylecode="Botrule ">
<paragraph>Renal-impaired adults:</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph>850 mg single dose</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<content stylecode="bold">Mild</content> (CL<sub>cr</sub> <footnote id="_RefIDFF22FC32379243068BA49AEF0293FCFB">CLcr = creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>.</footnote> 61-90 mL/min) (5)</paragraph>
</td>
<td align="center">
<paragraph>1.86 (± 0.52)</paragraph>
</td>
<td align="center">
<paragraph>3.20 (± 0.45)</paragraph>
</td>
<td align="center">
<paragraph>384 (± 122)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<content stylecode="bold">Moderate</content> (CL<sub>cr</sub> 31-60 mL/min) (4)</paragraph>
</td>
<td align="center">
<paragraph>4.12 (± 1.83)</paragraph>
</td>
<td align="center">
<paragraph>3.75 (± 0.50)</paragraph>
</td>
<td align="center">
<paragraph>108 (± 57)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>
<content stylecode="bold">Severe</content> (CL<sub>cr</sub> 10-30 mL/min) (6)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>3.93 (± 0.92)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>4.01 (± 1.10)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>130 (± 90)</paragraph>
</td>
</tr>
</tbody>
</table>